IGC Pharma increases authorized common stock from 150M to 600M shares

IGC Pharma, Inc.

Amendment effective Dec 12, 2025, after stockholder approval on Oct 10, 2025.
Authorized common stock raised from 150M to 600M shares; preferred stock unchanged at 1M shares.
Total authorized shares (all classes) increased from 151M to 601M shares.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

IGC Pharma, Inc.: Amended articles to increase authorized common stock from 150,000,000 to 600,000,000 shares (effective 2025-12-12).

Change: charter amendment
Effective: 2025-12-12

Exact text from the filing

Effective December 12, 2025, IGC Pharma, Inc. (the “Company”) amended its Amended and Restated Articles of Incorporation in order to give effect to a previously announced increase of its authorized common stock from 150,000,000 shares to 600,000,000 shares.

View on SEC.gov

272 governance changes filed in the last 30 days. Browse all governance changes →

IGC Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001185185-25-002055

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.